SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Alspaugh M, Henle G, Lennette E, Henle W. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest 1981; 67: 113440.
  • 2
    Tosato G, Steinberg A, Blaese M. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 1981; 305: 123843.
  • 3
    Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, et al. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984; 73: 178995.
  • 4
    Wilson SE, Bluestein HG, Zvaifler NJ. HLA-associated defective regulation of Epstein-Barr virus-induced proliferation of B lymphocytes in family members of rheumatoid arthritis patients [abstract]. Arthritis Rheum 1984; 27 Suppl 4: S71.
  • 5
    Toussirot E, Auger I, Roudier C, Luka J, Wendling D, Tiberghien P, et al. HLA–DR polymorphism influences T cell precursor frequencies to Epstein-Barr virus gp110: implications for the association of HLA–DR antigens with rheumatoid arthritis. Tissue Antigens 1999; 54: 14652.
    Direct Link:
  • 6
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 7
    Pieri Balandraud N, Roudier J, Roudier C. Quantification of human genomic DNA using retinoic X receptor B gene. In: Rapid cycle real time PCR, methods and applications: genetics and oncology. Berlin: Springer-Verlag; 2002. p. 2733.
  • 8
    Lightcycler operating manual. Mannheim (Germany): Roche Molecular Biochemicals; 1999. p. 669.
  • 9
    Smolen JS, Breedveld FC, Ebert G, Jones I, Leeming M, Wylie GL, et al. Validity and reliability of the twenty-eight–joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995; 38: 3843.
  • 10
    Glantz S. How to test for trends. In: GlantzS, editor. Primer of biostatistics. 3rd ed. New York: McGraw Hill; 1992. p. 2524.
  • 11
    Given D, Kieff E. DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. J Virol 1979; 31: 31524.
  • 12
    Allan GJ, Rowe DT. Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines. Virology 1989; 173: 48998.
  • 13
    Newkirk M, Duffy K, Paleckova A, Ivaskova E, Galianova A, Seeman J, et al. Herpes viruses in multicase families with rheumatoid arthritis. J Rheumatol 1995; 22: 205561.
  • 14
    Blaschke S, Schwarz G, Moneke D, Binder L, Muller G, Reuss-Bort M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000; 27: 86673.
  • 15
    Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 2000; 38: 6139.
  • 16
    Kimura H, Morito M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 1326.
  • 17
    Van Boekel M, Vossenaar E, van den Hoogen F, van Venrooij W. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Research 2002; 4: 8793.